FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Signe Engkjaer Christensen

Research Profile

Chemicals & Drugs

Disorders

Geographic Areas

Denmark

Procedures

Concepts & Ideas

Cross-Sectional Studies

Living Beings

Young Adult

Physiology

Co-author Network

Publications

TOP 3
Peter H Nissen; Signe Engkjaer Christensen; Andrew Wallace; Lene Heickendorff; Kim Brixen; Leif Mosekilde
Multiplex ligation-dependent probe amplification (MLPA) screening for exon copy number variation in the calcium sensing receptor gene: no large rearrangements identified in patients with calcium metabolic disorders.
Signe Engkjaer Christensen; Peter H Nissen; Peter Vestergaard; Lene Heickendorff; Lars Rejnmark; Kim Brixen; Leif Mosekilde
Skeletal consequences of familial hypocalciuric hypercalcaemia vs. primary hyperparathyroidism.
Signe Engkjaer Christensen; Peter H Nissen; Peter Vestergaard; Lene Heickendorff; Lars Rejnmark; Kim Brixen; Leif Mosekilde
Plasma 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and parathyroid hormone in familial hypocalciuric hypercalcemia and primary hyperparathyroidism.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Signe Engkjaer Christensen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Peter H Nissen; Signe Engkjaer Christensen; Andrew Wallace; Lene Heickendorff; Kim Brixen; Leif Mosekilde
Multiplex ligation-dependent probe amplification (MLPA) screening for exon copy number variation in the calcium sensing receptor gene: no large rearrangements identified in patients with calcium metabolic disorders.
Clinical endocrinology 2010;72(6):758-62.
2009: Signe Engkjaer Christensen; Peter H Nissen; Peter Vestergaard; Lene Heickendorff; Lars Rejnmark; Kim Brixen; Leif Mosekilde
Skeletal consequences of familial hypocalciuric hypercalcaemia vs. primary hyperparathyroidism.
Clinical endocrinology 2009;71(6):798-807.
2008: Signe Engkjaer Christensen; Peter H Nissen; Peter Vestergaard; Lene Heickendorff; Lars Rejnmark; Kim Brixen; Leif Mosekilde
Plasma 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and parathyroid hormone in familial hypocalciuric hypercalcemia and primary hyperparathyroidism.
European journal of endocrinology / European Federation of Endocrine Societies 2008;159(6):719-27.
2008: Signe Engkjaer Christensen; Peter H Nissen; Peter Vestergaard; Lene Heickendorff; Kim Brixen; Leif Mosekilde
Discriminative power of three indices of renal calcium excretion for the distinction between familial hypocalciuric hypercalcaemia and primary hyperparathyroidism: a follow-up study on methods.
Clinical endocrinology 2008;69(5):713-20.
2007: Peter H Nissen; Signe Engkjaer Christensen; Lene Heickendorff; Kim Brixen; Leif Mosekilde
Molecular genetic analysis of the calcium sensing receptor gene in patients clinically suspected to have familial hypocalciuric hypercalcemia: phenotypic variation and mutation spectrum in a Danish population.
The Journal of clinical endocrinology and metabolism 2007;92(11):4373-9.
2005: Signe Engkjaer Christensen; Peter H Nissen; Peter Schwarz
[Investigation and diagnosis of familial hypocalciuric hypercalcemia in Denmark].
Ugeskrift for laeger 2005;167(8):905-10.
2004: Signe Engkjaer Christensen; Thais A L D Pedersen; Claus Gravholt
[Extreme hypercalcemic crisis in a patient with malignant lymphoma].
Ugeskrift for laeger 2004;166(33):2813-4.